406 related articles for article (PubMed ID: 12894991)
1. Androgenetic alopecia in women.
Price VH
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):24-7. PubMed ID: 12894991
[TBL] [Abstract][Full Text] [Related]
2. Androgenetic alopecia.
Piraccini BM; Alessandrini A
G Ital Dermatol Venereol; 2014 Feb; 149(1):15-24. PubMed ID: 24566563
[TBL] [Abstract][Full Text] [Related]
3. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia.
Sawaya ME; Price VH
J Invest Dermatol; 1997 Sep; 109(3):296-300. PubMed ID: 9284093
[TBL] [Abstract][Full Text] [Related]
4. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
[TBL] [Abstract][Full Text] [Related]
5. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
6. [Androgenetic alopecia].
Jamin C
Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):801-3. PubMed ID: 12223962
[TBL] [Abstract][Full Text] [Related]
7. Trace elements content and hormonal profiles in women with androgenetic alopecia.
Skalnaya MG; Tkachev VP
J Trace Elem Med Biol; 2011 Jan; 25 Suppl 1():S50-3. PubMed ID: 21167696
[TBL] [Abstract][Full Text] [Related]
8. Hair loss in women.
Camacho-Martínez FM
Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
[TBL] [Abstract][Full Text] [Related]
9. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
10. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
11. Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.
Hoffmann R; Happle R
Eur J Dermatol; 2000; 10(5):410-7. PubMed ID: 10882953
[TBL] [Abstract][Full Text] [Related]
12. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
13. Female-patterned alopecia in teenage brothers with unusual histologic features.
Carlson JA; Malysz J; Schwartz J
J Cutan Pathol; 2006 Nov; 33(11):741-8. PubMed ID: 17083694
[TBL] [Abstract][Full Text] [Related]
14. Increased androgen receptor messenger RNA in frontal-parietal hair follicles of women with androgenetic alopecia.
Richeti F; Kochi C; Rocha MN; Sant'Anna Corrêa C; Lazzarini R; Guazzelli RM; Mendonça RF; Melo MR; Longui CA
Genet Mol Res; 2013 Jun; 12(2):1834-40. PubMed ID: 23479164
[TBL] [Abstract][Full Text] [Related]
15. Androgenetic alopecia in adolescents.
Price VH
Cutis; 2003 Feb; 71(2):115-21. PubMed ID: 12635889
[TBL] [Abstract][Full Text] [Related]
16. Occipital involvement in female pattern hair loss: histopathological evidences.
Ekmekci TR; Sakiz D; Koslu A
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):299-301. PubMed ID: 19703099
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal interaction and hair growth].
Hoffmann R
Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):787-92. PubMed ID: 12223960
[TBL] [Abstract][Full Text] [Related]
19. Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
Kaufman KD; Dawber RP
Expert Opin Investig Drugs; 1999 Apr; 8(4):403-15. PubMed ID: 15992088
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility.
Rossi A; D'Arino A; Pigliacelli F; Caro G; Muscianese M; Fortuna MC; Carlesimo M
Australas J Dermatol; 2019 Nov; 60(4):e279-e283. PubMed ID: 31168786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
